$RKDA
Arcadia Biosciences, Inc.

2021 Q4 Form 10-K Financial Statement

#000095017022005253 Filed on March 31, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $2.171M $6.780M $7.130M
YoY Change -69.55% -15.61% 1597.62%
Cost Of Revenue $1.954M $8.708M $540.0K
YoY Change 261.85% 67.49% -3.57%
Gross Profit $217.0K -$1.928M $6.590M
YoY Change -96.71% -168.01% -4493.33%
Gross Profit Margin 10.0% -28.44% 92.43%
Selling, General & Admin $5.404M $22.94M $4.780M
YoY Change 13.05% 39.3% 49.38%
% of Gross Profit 2490.32% 72.53%
Research & Development $495.0K $3.889M $1.960M
YoY Change -74.74% -51.14% 19.51%
% of Gross Profit 228.11% 29.74%
Depreciation & Amortization $209.0K $929.0K $260.0K
YoY Change -19.62% 46.99% 333.33%
% of Gross Profit 96.31% 3.95%
Operating Expenses $4.510M $26.83M $6.730M
YoY Change -32.99% 9.83% 38.76%
Operating Profit -$4.293M -$35.53M -$140.0K
YoY Change 2966.43% 178.02% -97.2%
Interest Expense $4.348M $20.00K $340.0K
YoY Change 1178.82% -57.45% -113.82%
% of Operating Profit
Other Income/Expense, Net -$100.0K $10.11M $660.0K
YoY Change -115.15% 1266.76% 450.0%
Pretax Income -$9.556M -$16.13M $8.470M
YoY Change -212.82% 162.31% -234.02%
Income Tax $1.000K $2.000K -$140.0K
% Of Pretax Income -1.65%
Net Earnings -$9.282M -$14.66M $8.900M
YoY Change -204.29% 214.93% -242.63%
Net Earnings / Revenue -427.54% -216.22% 124.82%
Basic Earnings Per Share -$27.56
Diluted Earnings Per Share -$418.2K -$688.9K $799.6K
COMMON SHARES
Basic Shares Outstanding 22.18M 532.0K
Diluted Shares Outstanding 532.0K

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.69M $28.69M $25.67M
YoY Change 11.75% 11.75% 1.34%
Cash & Equivalents $28.69M $28.69M $14.04M
Short-Term Investments $0.00 $0.00 $11.63M
Other Short-Term Assets $900.0K $900.0K $810.0K
YoY Change 11.11% 11.11% 14.08%
Inventory $4.433M $4.433M $3.812M
Prepaid Expenses
Receivables $1.370M $1.370M $1.406M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $35.39M $35.39M $31.70M
YoY Change 11.65% 11.63% 11.45%
LONG-TERM ASSETS
Property, Plant & Equipment $2.291M $5.372M $3.539M
YoY Change -35.26% -42.67% 96.72%
Goodwill $408.0K
YoY Change
Intangibles $484.0K $370.0K
YoY Change 30.81%
Long-Term Investments
YoY Change
Other Assets $180.0K $2.674M $23.00K
YoY Change 682.61% -51.47% 187.5%
Total Long-Term Assets $8.530M $8.530M $15.65M
YoY Change -45.5% -45.5% 278.62%
TOTAL ASSETS
Total Short-Term Assets $35.39M $35.39M $31.70M
Total Long-Term Assets $8.530M $8.530M $15.65M
Total Assets $43.92M $43.92M $47.35M
YoY Change -7.24% -7.25% 45.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $64.00K $1.475M $80.00K
YoY Change -20.0% 82.1% 100.0%
Accrued Expenses $1.074M $3.301M $720.0K
YoY Change 49.17% -19.49% 18.03%
Deferred Revenue $8.000K
YoY Change -80.95%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $1.140M
YoY Change -100.0% -100.0% 5600.0%
Total Short-Term Liabilities $5.040M $5.040M $6.314M
YoY Change -20.18% -20.13% 10.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $2.100M
YoY Change -100.0% -100.0% 1862.62%
Other Long-Term Liabilities $2.070M $7.682M $2.280M
YoY Change -9.21% -25.99% 14.0%
Total Long-Term Liabilities $2.070M $7.682M $4.380M
YoY Change -52.74% -38.49% 107.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.040M $5.040M $6.314M
Total Long-Term Liabilities $2.070M $7.682M $4.380M
Total Liabilities $12.72M $12.83M $18.80M
YoY Change -32.32% -34.63% -22.48%
SHAREHOLDERS EQUITY
Retained Earnings -$226.5M -$211.8M
YoY Change 6.92% 2.25%
Common Stock $257.6M $239.6M
YoY Change 7.53% 11.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $31.09M $31.09M $27.73M
YoY Change
Total Liabilities & Shareholders Equity $43.92M $43.92M $47.35M
YoY Change -7.24% -7.25% 45.36%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$9.282M -$14.66M $8.900M
YoY Change -204.29% 214.93% -242.63%
Depreciation, Depletion And Amortization $209.0K $929.0K $260.0K
YoY Change -19.62% 46.99% 333.33%
Cash From Operating Activities -$6.660M -$25.90M -$6.750M
YoY Change -1.33% -14.24% 34.73%
INVESTING ACTIVITIES
Capital Expenditures -$88.00K $1.007M -$300.0K
YoY Change -70.67% -56.87% -50.0%
Acquisitions $4.250M
YoY Change 750.0%
Other Investing Activities $18.00K $17.62M $3.150M
YoY Change -99.43% -10.22% -148.61%
Cash From Investing Activities -$70.00K $16.61M $2.850M
YoY Change -102.46% -3.91% -140.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -114.0K 21.90M 7.740M
YoY Change -101.47% 6.52% -38800.0%
NET CHANGE
Cash From Operating Activities -6.660M -25.90M -6.750M
Cash From Investing Activities -70.00K 16.61M 2.850M
Cash From Financing Activities -114.0K 21.90M 7.740M
Net Change In Cash -6.844M 12.64M 3.840M
YoY Change -278.23% 65.77% -131.71%
FREE CASH FLOW
Cash From Operating Activities -$6.660M -$25.90M -$6.750M
Capital Expenditures -$88.00K $1.007M -$300.0K
Free Cash Flow -$6.572M -$26.91M -$6.450M
YoY Change 1.89% -17.3% 46.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-37383
CY2021 dei Entity Registrant Name
EntityRegistrantName
Arcadia Biosciences, Inc.
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001469443
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-0571538
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
202 Cousteau Place
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 105
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Davis
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95618
CY2021 dei City Area Code
CityAreaCode
530
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
53245000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22188918
CY2021 dei Local Phone Number
LocalPhoneNumber
756-7077
CY2021 dei Security12b Title
Security12bTitle
Common
CY2021 dei Trading Symbol
TradingSymbol
RKDA
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28685000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14042000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
11625000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
76000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1370000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1406000
CY2021Q4 us-gaap Inventory Net
InventoryNet
4433000
CY2020Q4 us-gaap Inventory Net
InventoryNet
3812000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
900000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
811000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
35388000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
31696000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2001000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2291000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3539000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3081000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5826000
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2494000
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
3485000
CY2020Q4 us-gaap Goodwill
Goodwill
408000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
484000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
370000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
180000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23000
CY2021Q4 us-gaap Assets
Assets
43918000
CY2020Q4 us-gaap Assets
Assets
47348000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3638000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4105000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
64000
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
80000
CY2020Q4 us-gaap Debt Current
DebtCurrent
1141000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1074000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
239496000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
264000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
263000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-226485000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-211825000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
31093000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
27725000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
103000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
827000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31196000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28552000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43918000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47348000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6780000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
717000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8034000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8708000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5199000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3889000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7960000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5040000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6314000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2105000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2220000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5389000
CY2021Q4 rkda Common Stock Warrant Liabilities
CommonStockWarrantLiabilities
3392000
CY2020Q4 rkda Common Stock Warrant Liabilities
CommonStockWarrantLiabilities
2708000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2070000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2280000
CY2021Q4 us-gaap Liabilities
Liabilities
12722000
CY2020Q4 us-gaap Liabilities
Liabilities
18796000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22184235
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22184235
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13450861
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13450861
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
63000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
54000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
257515000
CY2020 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
8814000
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-497000
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3302000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1648000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-210000
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1534000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22938000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16467000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
42306000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
20812000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-35526000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-12778000
CY2021 us-gaap Interest Expense
InterestExpense
20000
CY2020 us-gaap Interest Expense
InterestExpense
47000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10114000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
740000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8946000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6570000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-635000
CY2021 rkda Gain Loss On Extinguishment Of Paycheck Protection Program Loan
GainLossOnExtinguishmentOfPaycheckProtectionProgramLoan
1123000
CY2021 us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
769000
CY2021 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-16132000
CY2020 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-6150000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-124000
CY2021 us-gaap Profit Loss
ProfitLoss
-16134000
CY2020 us-gaap Profit Loss
ProfitLoss
-6026000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1474000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1371000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-14660000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-4655000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.69
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.47
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21280620
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9959018
CY2020 rkda Other Comprehensive Income Unrealized Holding Gain Loss On Investment Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnInvestmentSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14660000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4656000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28552000
CY2021 rkda Stock Issued During Period Value Related To Exercise Of Services And Performance Warrants
StockIssuedDuringPeriodValueRelatedToExerciseOfServicesAndPerformanceWarrants
22000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
38000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1541000
CY2021 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
750000
CY2021 us-gaap Profit Loss
ProfitLoss
-16134000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31196000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8325000
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
51000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2042000
CY2020 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1578000
CY2020 rkda Other Comprehensive Income Unrealized Holding Gain Loss On Investment Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnInvestmentSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
76000
CY2020 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
8814000
CY2021 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-10221000
CY2020 us-gaap Profit Loss
ProfitLoss
-6026000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28552000
CY2021 us-gaap Profit Loss
ProfitLoss
-16134000
CY2020 us-gaap Profit Loss
ProfitLoss
-6026000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8946000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6570000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-210000
CY2021 us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
769000
CY2021 us-gaap Depreciation
Depreciation
929000
CY2020 us-gaap Depreciation
Depreciation
632000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
116000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1276000
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1048000
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3302000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1648000
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-23000
CY2020 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
8000
CY2021 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-222000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
44000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1541000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2042000
CY2020 rkda Corporate Securities Received In Exchange For License Agreement
CorporateSecuritiesReceivedInExchangeForLicenseAgreement
4318000
CY2020 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
656000
CY2021 rkda Inventory Write Down And Prepaid Production Costs
InventoryWriteDownAndPrepaidProductionCosts
3593000
CY2020 rkda Inventory Write Down And Prepaid Production Costs
InventoryWriteDownAndPrepaidProductionCosts
4311000
CY2020 rkda Loss On Extinguishment Of Warrant Liability
LossOnExtinguishmentOfWarrantLiability
-635000
CY2021 rkda Gain Loss On Extinguishment Of Paycheck Protection Program Loan
GainLossOnExtinguishmentOfPaycheckProtectionProgramLoan
1123000
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1534000
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-107000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
40000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1119000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2383000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9751000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-56000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-39000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
158000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
15000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-372000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-580000
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-16000
CY2020 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
40000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-8000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-34000
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1000
CY2020 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-43000
CY2021 rkda Increase Decrease In Operating Lease Payments
IncreaseDecreaseInOperatingLeasePayments
-1343000
CY2020 rkda Increase Decrease In Operating Lease Payments
IncreaseDecreaseInOperatingLeasePayments
-910000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25868000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30218000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
19000
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
8000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1007000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2335000
CY2020 us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
3153000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4250000
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
500000
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1292000
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
21846000
CY2020 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
18250000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16608000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17284000
CY2020 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
3108000
CY2020 rkda Payments Of Transaction Costs Relating To Extinguishment Of Warrant Liability
PaymentsOfTransactionCostsRelatingToExtinguishmentOfWarrantLiability
863000
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2146000
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
34000
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
22000
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
9372000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
39000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
51000
CY2021 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
750000
CY2020 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
1578000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21900000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20560000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12642000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7626000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16043000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8417000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28685000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16043000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
25000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
10000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1664000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
331000
CY2020 rkda Right Of Use Assets Obtained Through Modification Of Existing Lease Agreement
RightOfUseAssetsObtainedThroughModificationOfExistingLeaseAgreement
4207000
CY2020 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
37000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
71000
CY2021 rkda Entity Place Of Incorporation
EntityPlaceOfIncorporation
Arizona
CY2021 rkda Entity Incorporation Year Of Incorporation
EntityIncorporationYearOfIncorporation
2002
CY2021 rkda Entity Reincorporation State Country Name
EntityReincorporationStateCountryName
Delaware
CY2021 rkda Entity Reincorporation Date Of Reincorporation
EntityReincorporationDateOfReincorporation
2015-03
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-497000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1400000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-226500000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28700000
CY2021 us-gaap Profit Loss
ProfitLoss
-16100000
CY2020 us-gaap Profit Loss
ProfitLoss
-6000000.0
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25900000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30200000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1474000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1371000
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-497000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions in the Company’s consolidated financial statements and notes thereto. Significant estimates and assumptions made by management included the determination of the provision for income taxes, stock-based compensation, impairments of long-lived assets such as intangible assets and goodwill, impairment of property and equipment,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and net realizable value of inventory. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates.</span></p>
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
76000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3300000
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1600000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1600000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash and cash equivalents are maintained with several financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with financial institutions with reputable credit and therefore bear minimal credit risk. The Company seeks to mitigate its credit risks by spreading such risks across multiple counterparties and monitoring the risk profiles of these counterparties.</span></p>
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1541000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2042000
CY2021 rkda Contract With Customer Liability Recognition Of Unearned Revenue
ContractWithCustomerLiabilityRecognitionOfUnearnedRevenue
8000
CY2021Q4 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
1851000
CY2020Q4 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
966000
CY2021Q4 rkda Inventory Goods In Process Current And Non Current
InventoryGoodsInProcessCurrentAndNonCurrent
842000
CY2020Q4 rkda Inventory Goods In Process Current And Non Current
InventoryGoodsInProcessCurrentAndNonCurrent
1921000
CY2021Q4 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
4234000
CY2020Q4 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
4410000
CY2021Q4 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
6927000
CY2020Q4 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
7297000
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
3600000
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
4300000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7950000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8426000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5659000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4887000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2291000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3539000
CY2021 us-gaap Depreciation
Depreciation
929000
CY2020 us-gaap Depreciation
Depreciation
632000
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1500000
CY2020 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1400000
CY2021 rkda Additional Fixed Assets Impairment
AdditionalFixedAssetsImpairment
100000
CY2021 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
10200000
CY2021Q4 rkda Debt And Equity Securities Amortized Cost Basis
DebtAndEquitySecuritiesAmortizedCostBasis
26842000
CY2021Q4 rkda Debt And Equity Securities
DebtAndEquitySecurities
26842000
CY2020Q4 rkda Debt And Equity Securities Amortized Cost Basis
DebtAndEquitySecuritiesAmortizedCostBasis
23051000
CY2020Q4 rkda Debt And Equity Securities Accumulated Gross Unrealized Gain Before Tax
DebtAndEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
656000
CY2020Q4 rkda Debt And Equity Securities
DebtAndEquitySecurities
23707000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
26842000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
23707000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
970000
CY2021Q4 rkda Finite Lived Intangible Assets Accumulated Amortization And Impairment
FiniteLivedIntangibleAssetsAccumulatedAmortizationAndImpairment
774000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
196000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
350000
CY2020Q4 rkda Finite Lived Intangible Assets Accumulated Amortization And Impairment
FiniteLivedIntangibleAssetsAccumulatedAmortizationAndImpairment
30000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
320000
CY2021Q4 rkda Indefinite Lived Intangible Assets Excluding Goodwill Gross
IndefiniteLivedIntangibleAssetsExcludingGoodwillGross
3920000
CY2021Q4 rkda Indefinite Lived Intangible Assets Accumulated Amortization And Impairment
IndefiniteLivedIntangibleAssetsAccumulatedAmortizationAndImpairment
3436000
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
484000
CY2020Q4 rkda Indefinite Lived Intangible Assets Excluding Goodwill Gross
IndefiniteLivedIntangibleAssetsExcludingGoodwillGross
400000
CY2020Q4 rkda Indefinite Lived Intangible Assets Accumulated Amortization And Impairment
IndefiniteLivedIntangibleAssetsAccumulatedAmortizationAndImpairment
30000
CY2020Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
370000
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3300000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
152000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
162000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
164000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3638000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4105000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
53000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
53000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
53000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
4000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
28000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
196000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1474000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1371000
CY2021Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
22200000
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1411000
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
726000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1606000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1489000
CY2021Q4 rkda Accrued Inventory
AccruedInventory
72000
CY2020Q4 rkda Accrued Inventory
AccruedInventory
965000
CY2020Q4 rkda Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
45000
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
51000
CY2020Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
276000
CY2021Q4 rkda Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
79000
CY2020Q4 rkda Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
153000
CY2021Q4 rkda Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
127000
CY2020Q4 rkda Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
78000
CY2021Q4 rkda Accrued Audit And Tax Fees
AccruedAuditAndTaxFees
72000
CY2020Q4 rkda Accrued Audit And Tax Fees
AccruedAuditAndTaxFees
57000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
58000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.91
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.60
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
305000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
502494
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.28
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
174508
CY2021 us-gaap Registration Payment Arrangement Term
RegistrationPaymentArrangementTerm
This registration statement expired on its three-year anniversary, June 8, 2021.
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5463620
CY2021 rkda Stock Issued During Period Shares Related To Exercise Of Warrants
StockIssuedDuringPeriodSharesRelatedToExerciseOfWarrants
-30000
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5834959
CY2021 rkda Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
661701
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
99928
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
25.56
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
889759
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.46
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
240000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1227042
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.76
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
440166
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.09
CY2021 rkda Share Based Compensation Arrangement By Share Based Payment Award Forfeiture Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeitureOutstandingIntrinsicValue
1086000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
254440
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
29.02
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1422195
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.28
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1322111
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.47
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
743109
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.54
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1100000
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.41
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.80
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1500000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2000000.0
CY2021 rkda Milestones Payments Yet To Be Achieved
MilestonesPaymentsYetToBeAchieved
2000000.0
CY2020 rkda Milestones Payments Yet To Be Achieved
MilestonesPaymentsYetToBeAchieved
2000000.0
CY2021 rkda Milestones Payment
MilestonesPayment
0
CY2020 rkda Milestones Payment
MilestonesPayment
0
CY2021 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
Some leases (the Davis office, warehouse, greenhouses and a copy machine) include one or more options to renew, with renewal terms that can extend the lease term from one to six years.
CY2021 us-gaap Lessee Operating Sublease Option To Extend
LesseeOperatingSubleaseOptionToExtend
lease amendment that provided for additional office space in Davis, CA, and extended the term through April 2025, with one option to renew for an additional five-year term. The Company initially expected to exercise its options to renew, and in accordance with ASC 842, Leases, accounted for the amendment and expected renewal as a lease modification and remeasured the operating lease liability.
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3081000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5826000
CY2021Q4 rkda Operating Lease Assets
OperatingLeaseAssets
3081000
CY2020Q4 rkda Operating Lease Assets
OperatingLeaseAssets
5826000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1074000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
717000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2220000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5389000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3294000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6106000
CY2021 us-gaap Lease Cost
LeaseCost
1422000
CY2020 us-gaap Lease Cost
LeaseCost
1302000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1217000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1237000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
973000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
168000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3595000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
301000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3294000
CY2021Q4 us-gaap Debt Current
DebtCurrent
0
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2020Q4 us-gaap Debt Current
DebtCurrent
1100000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2100000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-16006000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-6150000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-126000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16132000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6150000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-124000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-28000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-10000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-18000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
84000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
22000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-106000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-124000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.201
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.094
CY2021 rkda Effective Income Tax Rate Reconciliation Impact Of Ownership Change
EffectiveIncomeTaxRateReconciliationImpactOfOwnershipChange
-0.104
CY2020 rkda Effective Income Tax Rate Reconciliation Impact Of Ownership Change
EffectiveIncomeTaxRateReconciliationImpactOfOwnershipChange
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.004
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.438
CY2021 rkda Effective Income Tax Rate Reconciliation Transaction Costs Percentage
EffectiveIncomeTaxRateReconciliationTransactionCostsPercentage
-0.010
CY2020 rkda Effective Income Tax Rate Reconciliation Transaction Costs Percentage
EffectiveIncomeTaxRateReconciliationTransactionCostsPercentage
-0.022
CY2021 rkda Effective Income Tax Rate Reconciliation Derivative Liabilities Percentage
EffectiveIncomeTaxRateReconciliationDerivativeLiabilitiesPercentage
0.117
CY2020 rkda Effective Income Tax Rate Reconciliation Derivative Liabilities Percentage
EffectiveIncomeTaxRateReconciliationDerivativeLiabilitiesPercentage
0.224
CY2021 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
-0.019
CY2020 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
-0.047
CY2021 rkda Effective Income Tax Rate Reconciliation Gain Loss On Debt Extinguishment
EffectiveIncomeTaxRateReconciliationGainLossOnDebtExtinguishment
0.015
CY2020 rkda Effective Income Tax Rate Reconciliation Gain Loss On Debt Extinguishment
EffectiveIncomeTaxRateReconciliationGainLossOnDebtExtinguishment
0
CY2021 rkda Effective Income Tax Rate Reconciliation Withholding Taxes
EffectiveIncomeTaxRateReconciliationWithholdingTaxes
0
CY2020 rkda Effective Income Tax Rate Reconciliation Withholding Taxes
EffectiveIncomeTaxRateReconciliationWithholdingTaxes
-0.002
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.004
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.019
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14586000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15478000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
2000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3677000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3881000
CY2021Q4 rkda Deferred Tax Assets Accrued Payroll And Benefits
DeferredTaxAssetsAccruedPayrollAndBenefits
3000
CY2020Q4 rkda Deferred Tax Assets Accrued Payroll And Benefits
DeferredTaxAssetsAccruedPayrollAndBenefits
236000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
16000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
16000
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
73000
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
84000
CY2021Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
422000
CY2020Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
491000
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
2000
CY2020Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
3000
CY2021Q4 rkda Deferred Tax Asset Income From Partnerships
DeferredTaxAssetIncomeFromPartnerships
163000
CY2020Q4 rkda Deferred Tax Asset Income From Partnerships
DeferredTaxAssetIncomeFromPartnerships
0
CY2021Q4 rkda Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
752000
CY2020Q4 rkda Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
1622000
CY2021Q4 rkda Deferred Tax Asset Contingent Consideration
DeferredTaxAssetContingentConsideration
456000
CY2020Q4 rkda Deferred Tax Asset Contingent Consideration
DeferredTaxAssetContingentConsideration
531000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
27000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
0
CY2021Q4 rkda Deferred Tax Assets Amortized Intangibles
DeferredTaxAssetsAmortizedIntangibles
660000
CY2020Q4 rkda Deferred Tax Assets Amortized Intangibles
DeferredTaxAssetsAmortizedIntangibles
0
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
366000
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
0
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
21204000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
22344000
CY2021Q4 rkda Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
699000
CY2020Q4 rkda Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
1548000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
0
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
98000
CY2021Q4 rkda Deferred Tax Liabilities Income From Partnerships
DeferredTaxLiabilitiesIncomeFromPartnerships
0
CY2020Q4 rkda Deferred Tax Liabilities Income From Partnerships
DeferredTaxLiabilitiesIncomeFromPartnerships
13000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
174000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
699000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1833000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20505000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20511000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-6000000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1900000
CY2021 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
it has not forfeited the right to carryforward tax losses up to 20 years
CY2021 rkda Income Tax Examination Year Subject Under Examination
IncomeTaxExaminationYearSubjectUnderExamination
2002
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
2000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
15000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17000
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2021 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.03
CY2021 us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
Employees’ rights to employer contributions vest on the one-year anniversary of their date of employment.
CY2021 rkda Defined Benefit Plan Contribution Vesting Period
DefinedBenefitPlanContributionVestingPeriod
P1Y
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6780000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8034000
CY2020Q2 rkda Number Of Lease Amendments
NumberOfLeaseAmendments
2
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
84000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
84000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12932206
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8090039
CY2021 dei Auditor Firm
AuditorFirmId
34
CY2021 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2021 dei Auditor Location
AuditorLocation
Phoenix, AZ

Files In Submission

Name View Source Status
0000950170-22-005253-index-headers.html Edgar Link pending
0000950170-22-005253-index.html Edgar Link pending
0000950170-22-005253.txt Edgar Link pending
0000950170-22-005253-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img201690542_0.jpg Edgar Link pending
img67890739_0.jpg Edgar Link pending
img67890739_1.jpg Edgar Link pending
img67890739_2.jpg Edgar Link pending
img67890739_3.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
report.css Edgar Link pending
rkda-20211231.htm Edgar Link pending
rkda-20211231.xsd Edgar Link pending
rkda-20211231_cal.xml Edgar Link unprocessable
rkda-20211231_def.xml Edgar Link unprocessable
rkda-20211231_htm.xml Edgar Link completed
rkda-20211231_lab.xml Edgar Link unprocessable
rkda-20211231_pre.xml Edgar Link unprocessable
rkda-ex10_27.htm Edgar Link pending
rkda-ex23_1.htm Edgar Link pending
rkda-ex31_1.htm Edgar Link pending
rkda-ex31_2.htm Edgar Link pending
rkda-ex32_1.htm Edgar Link pending
rkda-ex32_2.htm Edgar Link pending
Show.js Edgar Link pending